Skip to main content
. 2022 Aug 3;12:13361. doi: 10.1038/s41598-022-17579-0

Figure 10.

Figure 10

Circulating bone marker levels are not altered by miR-101a over-expression male and female mice. Terminal serum samples were collected from male and female R26 control and miR-101a over-expressing (R26/101a) mice treated with doxycycline from inception to sacrifice (8 weeks). Circulating levels of P1NP and CTX were assessed by commercial ELISA kits.